Jenscare Scientific Co., Ltd. (9877.HK)
HKD 5.61
(-3.77%)
HKD 5.61
(-3.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 421.28 Million | 500.57 Million | 503.19 Million | 300.71 Million |
| Selling, General and Administrative Expenses | 150.3 Million | 49.62 Million | 38.52 Million | 2.94 Million |
| Research and Development Expenses | 288.15 Million | 291.58 Million | 265.33 Million | 170.62 Million |
| Other Expenses | - | -96 Thousand | -6.94 Million | 3000.00 |
| Cost and Expenses | 438.46 Million | 500.57 Million | 503.19 Million | 300.71 Million |
| Operating Income | -438.46 Million | -441.52 Million | -507.03 Million | -300.58 Million |
| Interest Expense | 142 Thousand | 113 Thousand | 130 Thousand | 594 Thousand |
| Income Tax Expense | - | -1.6 Million | -156 Thousand | -226 Thousand |
| Earnings before Tax | -379.09 Million | -440.91 Million | -500.67 Million | -299.67 Million |
| Net Income | -371.73 Million | -439.31 Million | -500.51 Million | -299.44 Million |
| Earnings Per Share Basic | -0.89 | -1.20 | -1.48 | -1.07 |
| Earnings Per Share Diluted | -0.89 | -1.20 | -1.48 | -1.07 |
| Weighted Average Shares Outstanding | 417.16 Million | 365.37 Million | 338.44 Million | 278.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 417.16 Million | 365.37 Million | 338.44 Million | 278.71 Million |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -429.67 Million | -504.82 Million | -501.76 Million | -297.24 Million |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 104.71 Thousand | 421.28 Million | 104.71 Thousand | 94.42 Thousand | 94.42 Thousand | 187.11 Thousand |
| Selling, General and Administrative Expenses | 34.08 Thousand | - | 34.08 Thousand | 41.06 Thousand | 41.06 Thousand | 89.58 Thousand |
| Research and Development Expenses | 75.27 Thousand | - | 75.27 Thousand | 68.8 Thousand | 68.8 Thousand | 103.51 Thousand |
| Other Expenses | - | 1.05 Million | - | - | - | - |
| Cost and Expenses | 104.71 Thousand | 421.28 Million | 104.71 Thousand | 94.42 Thousand | 94.42 Thousand | 187.11 Thousand |
| Operating Income | -109.36 Thousand | -378.78 Million | -109.36 Thousand | -109.87 Thousand | -109.87 Thousand | -193.1 Thousand |
| Interest Expense | - | 142 Thousand | - | - | - | - |
| Income Tax Expense | -2476.00 | -7.36 Million | -2476.00 | -1204.00 | -1204.00 | -463.00 |
| Earnings before Tax | -100.46 Thousand | -379.09 Million | -100.46 Thousand | -89.08 Thousand | -89.08 Thousand | -183.69 Thousand |
| Net Income | -97.99 Million | -371.73 Million | -97.99 Million | -87.87 Million | -87.87 Million | -183.22 Million |
| Earnings Per Share Basic | -0.23 | - | -0.23 | -0.21 | -0.21 | -0.50 |
| Earnings Per Share Diluted | -0.23 | - | -0.23 | -0.21 | -0.21 | -0.50 |
| Weighted Average Shares Outstanding | 417.16 Million | 417.16 Million | 417.16 Million | 417.16 Million | 417.16 Million | 367.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 417.16 Million | 417.16 Million | 417.16 Million | 417.16 Million | 417.16 Million | 367.93 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -107.21 Thousand | - | -107.21 Thousand | -107.61 Thousand | -107.61 Thousand | -191.32 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
4126
DPABHUSHAN
8103
1868
MYNA
RACLGEAR